Trials / Conditions / Choroidal Neovascularisation
Choroidal Neovascularisation
3 registered clinical trials studyying Choroidal Neovascularisation.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Resveratrol for Exudative Age-Related Macular Degeneration NCT02625376 | Poitiers University Hospital | N/A |
| Completed | Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an NCT01037348 | Novartis | Phase 2 |
| Unknown | Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous Maculopathy NCT00344617 | Singapore National Eye Centre | Phase 3 |